Therefore, our study suggests that placental OPG may be a crucial molecule for the modulation of the crosstalk between CNS and the immune system of the mother, and for the recognized beneficial effect of late pregnancy in MS patients. This evidence concerns the gene TNFRSF11B and myeloid sarcoma.